Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Author Archives: MissionIR

Vapor Corp. (VPCO) Starts Presentation at 2nd Annual Marcum MicroCap Conference

Vapor is an electronic cigarette company, whose brands include Fifty-One®, Krave®, VaporX®, EZ Smoker®, Alternacig®, Green Puffer®, Americig®, Fumare™, Hookah Stix™ and Smoke Star®. The company also designs and develops private label brands for some of its distribution customers. VPCO’s … Continue reading

Posted in Marcum MicroCap | Leave a comment

Glyeco, Inc. (GLYE) Starts Presentation at 2nd Annual Marcum MicroCap Conference

Glyeco is a green chemistry company with a patent-pending technology for transforming a hazardous waste into green products. GlyEco Technology™ is capable of cleaning the polluted glycols from all five waste-producing industries: HVAC, textiles, automotive, airline and medical. This technology … Continue reading

Posted in Marcum MicroCap | Leave a comment

Pulse Seismic, Inc. (PLSDF) Starts Presentation at 2nd Annual Marcum MicroCap Conference

Pulse Seismic acquires, markets and licenses 2D and 3D seismic data to the western Canadian energy sector. The company is the owner of the second-largest licensable seismic data library in Canada, currently consisting of approximately 28,300 net square kilometres of … Continue reading

Posted in Marcum MicroCap | Leave a comment

Blue Calypso, Inc. (BCYP) Starts Presentation at 2nd Annual Marcum MicroCap Conference

Blue Calypso is engaged in the innovation of digital word-of-mouth marketing and advertising. Utilizing its patented platform, BCYP offers brands the ability to use friend-to-friend referrals by empowering their advocates to share brand content with their unique social graph and … Continue reading

Posted in Marcum MicroCap | Leave a comment

Provectus Pharmaceuticals, Inc. (PVCT) Starts Presentation at 2nd Annual Marcum MicroCap Conference

Provectus Pharmaceuticals is focused on developing oncology and dermatology therapies. The company’s novel oncology drug, PV-10, is designed to selectively target and destroy cancer cells without harming surrounding healthy tissue, significantly reducing potential for systemic side effects. PVCT’s oncology focus … Continue reading

Posted in Marcum MicroCap | Leave a comment

Medifocus, Inc. (MDFZF) Starts Presentation at 2nd Annual Marcum MicroCap Conference

Medifocus develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate, medically known as Benign Prostatic Hyperplasia (“BPH”). The company owns two technology platforms with approximately 100 issued and pending U.S. … Continue reading

Posted in Marcum MicroCap | Leave a comment

Atossa Genetics, Inc. (ATOS) Starts Presentation at 2nd Annual Marcum MicroCap Conference

Atossa Genetics, The Breast Health Company™, is focused on preventing breast cancer through the commercialization of patented, FDA-designated Class II diagnostic medical devices and patented, laboratory developed tests (LDT) that can detect precursors to breast cancer up to eight years … Continue reading

Posted in Marcum MicroCap | Leave a comment

NetDimensions Holdings Ltd. (NETDY) Starts Presentation at 2nd Annual Marcum MicroCap Conference

NetDimensions Holdings on a global scale provides performance, knowledge and learning management systems, providing organizations with talent management solutions to personalize learning, share knowledge, enhance performance, foster collaboration, and manage compliance programs for employees, customers, partners and suppliers. The company’s … Continue reading

Posted in Marcum MicroCap | Leave a comment

NTS Communications, Inc. (NTS) Starts Presentation at 2nd Annual Marcum MicroCap Conference

NTS Communications provides high-speed broadband services, including Internet access, digital cable TV programming and local and long distance telephone service to residential and business customers in northern Texas and southeastern Louisiana. The Company currently has operations in Texas, Mississippi and … Continue reading

Posted in Marcum MicroCap | Leave a comment

Prima BioMed Ltd. (PBMD) Starts Presentation at 2nd Annual Marcum MicroCap Conference

Prima BioMed is a biotechnology company developing personalized bio-therapeutic products for cancer in Australia. The company’s lead product is CVac™, an autologous dendritic cell-based product currently in clinical trials for ovarian cancer patients in remission and soon to be in … Continue reading

Posted in Marcum MicroCap | Leave a comment